Emerging Horizons in Oncology: Cyclin E1 Emerges as a Pivotal Target for Oral Cell Cycle Inhibitors
Introduction and Main Facts The landscape of modern oncology is undergoing a paradigm shift, driven…
Tag: oncology
AI-Powered Oncology Specialist Iambic Therapeutics Targets $135m Nasdaq IPO Amid Bumper Year for Biotech
NEW YORK — Iambic Therapeutics, an oncology-focused biotechnology company backed by high-profile venture capital and…
